Acarbose in NIDDM Patients With Poor Control on Conventional Oral Agents: A 24-week placebo-controlled study

Abstract

In NIDDM patients inadequately controlled on conventional oral agents, acarbose in moderate doses resulted in beneficial effects on glycemic control, especially postprandial glycemia, and mean body weight. Additional use of acarbose can be considered as a useful alternative in such patients if they are reluctant to accept insulin therapy.